About 32 results
Open links in new tab
  1. Pipeline - Providence Therapeutics

    Discover Providence Therapeutics Cutting-edge mRNA pipeline in infectious diseases and oncology.

  2. mRNA Medicines Platform - Providence Therapeutics

    Our clinically validated platform is built using a proprietary mRNA design algorithm that utilizes advanced codon optimization, resulting in improved translation and highly efficient immune modulation. We …

  3. Providence and Ontario Institute for Cancer Research (OICR) partnering ...

    Providence has a robust pipeline consisting of preclinical and clinical oncology, infectious diseases, and animal health programs. These programs have been developed internally and in collaboration with …

  4. News & Media - Providence Therapeutics

    Company About Us Careers & Culture Foundations of Providence Providence History Useful Links Business Development Investors Pipeline News Privacy Policy

  5. Providence Therapeutics Home - Providence Therapeutics

    Pipeline Discover Providence's Cutting-Edge mRNA Pipeline in Infectious Diseases & Oncology Oncology Infectious Diseases Animal Health

  6. Article details - Providence Therapeutics

    Providence has a robust pipeline consisting of preclinical and clinical oncology, infectious diseases, and animal health programs. These programs have been developed internally and in collaboration with …

  7. Providence Therapeutics Announces New mRNA Rabies Vaccine …

    Dec 15, 2022 · “We look forward to continuing to advance our rabies mRNA vaccine program with Everest as a critical part of a growing pipeline of mRNA vaccine candidates for infectious diseases …

  8. After matching Comirnaty, Providence plans phase 3 booster study ...

    Company About Us Careers & Culture Foundations of Providence Providence History Useful Links Business Development Investors Pipeline News Privacy Policy

  9. Press - Providence Therapeutics

    Nov 28, 2022 · Article detailsProvidence Therapeutics Presents Phase 2 Data on its mRNA COVID-19 Vaccine Candidate PTX-COVID19-B at the 2022 World Vaccine & Immunotherapy Congress …

  10. Providence Therapeutics Signs Licensing Agreement with SickKids for ...

    Providence Therapeutics, an emerging specialty Biopharma, has successfully developed a robust, scalable, and effective mRNA medicine platform as exemplified by the clinical success of PTX …